• Je něco špatně v tomto záznamu ?

The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis

L. Borsoi, P. Armeni, G. Donin, F. Costa, L. Ferini-Strambi

. 2022 ; 17 (5) : e0268677. [pub] 20220520

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, systematický přehled, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018354

BACKGROUND: Obstructive sleep apnea (OSA) is a risk factor for several diseases and is correlated with other non-medical consequences that increase the disease's clinical and economic burden. However, OSA's impact is highly underestimated, also due to substantial diagnosis gaps. OBJECTIVE: This study aims at assessing the economic burden of OSA in the adult population in Italy by performing a cost-of-illness analysis with a societal perspective. In particular, we aimed at estimating the magnitude of the burden caused by conditions for which OSA is a proven risk factor. METHODS: A systematic literature review on systematic reviews and meta-analyses, integrated by expert opinion, was performed to identify all clinical and non-clinical conditions significantly influenced by OSA. Using the Population Attributable Fraction methodology, a portion of their prevalence and costs was attributed to OSA. The total economic burden of OSA for the society was estimated by summing the costs of each condition influenced by the disease, the costs due to OSA's diagnosis and treatment and the economic value of quality of life lost due to OSA's undertreatment. RESULTS: Twenty-six clinical (e.g., diabetes) and non-clinical (e.g., car accidents) conditions were found to be significantly influenced by OSA, contributing to an economic burden ranging from €10.7 to €32.0 billion/year in Italy. The cost of impaired quality of life due to OSA undertreatment is between €2.8 and €9.0 billion/year. These costs are substantially higher than those currently borne to diagnose and treat OSA (€234 million/year). CONCLUSIONS: This study demonstrates that the economic burden due to OSA is substantial, also due to low diagnosis and treatment rates. Providing reliable estimates of the economic impact of OSA at a societal level may increase awareness of the disease burden and help to guide evidence-based policies and prioritisation for healthcare, ultimately ensuring appropriate diagnostic and therapeutic pathways for patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018354
003      
CZ-PrNML
005      
20220804134725.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0268677 $2 doi
035    __
$a (PubMed)35594257
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Borsoi, Ludovica $u SDA Bocconi School of Management, Centre for Research on Health and Social Care Management (CERGAS), Milan, Italy $1 https://orcid.org/0000000194786451
245    14
$a The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis / $c L. Borsoi, P. Armeni, G. Donin, F. Costa, L. Ferini-Strambi
520    9_
$a BACKGROUND: Obstructive sleep apnea (OSA) is a risk factor for several diseases and is correlated with other non-medical consequences that increase the disease's clinical and economic burden. However, OSA's impact is highly underestimated, also due to substantial diagnosis gaps. OBJECTIVE: This study aims at assessing the economic burden of OSA in the adult population in Italy by performing a cost-of-illness analysis with a societal perspective. In particular, we aimed at estimating the magnitude of the burden caused by conditions for which OSA is a proven risk factor. METHODS: A systematic literature review on systematic reviews and meta-analyses, integrated by expert opinion, was performed to identify all clinical and non-clinical conditions significantly influenced by OSA. Using the Population Attributable Fraction methodology, a portion of their prevalence and costs was attributed to OSA. The total economic burden of OSA for the society was estimated by summing the costs of each condition influenced by the disease, the costs due to OSA's diagnosis and treatment and the economic value of quality of life lost due to OSA's undertreatment. RESULTS: Twenty-six clinical (e.g., diabetes) and non-clinical (e.g., car accidents) conditions were found to be significantly influenced by OSA, contributing to an economic burden ranging from €10.7 to €32.0 billion/year in Italy. The cost of impaired quality of life due to OSA undertreatment is between €2.8 and €9.0 billion/year. These costs are substantially higher than those currently borne to diagnose and treat OSA (€234 million/year). CONCLUSIONS: This study demonstrates that the economic burden due to OSA is substantial, also due to low diagnosis and treatment rates. Providing reliable estimates of the economic impact of OSA at a societal level may increase awareness of the disease burden and help to guide evidence-based policies and prioritisation for healthcare, ultimately ensuring appropriate diagnostic and therapeutic pathways for patients.
650    _2
$a dospělí $7 D000328
650    _2
$a osobní újma zaviněná nemocí $7 D017281
650    _2
$a poskytování zdravotní péče $7 D003695
650    _2
$a finanční stres $7 D000086522
650    _2
$a náklady na zdravotní péči $7 D017048
650    _2
$a lidé $7 D006801
650    12
$a kvalita života $7 D011788
650    12
$a obstrukční spánková apnoe $x epidemiologie $x terapie $7 D020181
655    _2
$a časopisecké články $7 D016428
655    _2
$a systematický přehled $7 D000078182
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Armeni, Patrizio $u SDA Bocconi School of Management, Centre for Research on Health and Social Care Management (CERGAS), Milan, Italy
700    1_
$a Donin, Gleb $u Department of Biomedical Technology, Czech Technical University in Prague, Kladno, Czech Republic $1 https://orcid.org/0000000337865932 $7 xx0219312
700    1_
$a Costa, Francesco $u SDA Bocconi School of Management, Centre for Research on Health and Social Care Management (CERGAS), Milan, Italy
700    1_
$a Ferini-Strambi, Luigi $u Faculty of Psychology, Vita-Salute San Raffaele University, Milan, Italy
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 17, č. 5 (2022), s. e0268677
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35594257 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134719 $b ABA008
999    __
$a ok $b bmc $g 1822111 $s 1169597
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 17 $c 5 $d e0268677 $e 20220520 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

    Možnosti archivace